One possible approach is identifying high-risk individuals with genetic predispositions (e.g., PD-linked variants in SNCA, GBA1, and LRRK2), and tracking microbiome compositions as they age until PD symptoms emerge. The gene discussed is GBA1; the disease is Parkinson disease.